DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Epigral Limited — Investor Presentation

NSE 1 hr ago·27 Jul 2026, 8:46 am

Epigral

Epigral Limited has announced the release of its investor presentation, a document that typically outlines the company's future strategy, financial targets, and operational roadmap. This update is a routine communication tool used by firms to keep shareholders informed about their progress and upcoming plans.

For investors, this presentation is a key resource to gauge management's confidence and assess the company's growth trajectory. It provides a clearer picture of how Epigral intends to utilize its resources and compete in the market.

Investors should pay close attention to the guidance provided regarding production volumes, capacity expansion, and cost management. These details are crucial for understanding the company's potential to generate future earnings.